Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

N 696

Known as: N-696 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
  • Robert J. Mayer
  • Journal of clinical oncology : official journal…
  • 2012
  • Corpus ID: 46372153
The ability of adjuvant fluorouracil-based therapy to significantly enhance survival in patients with stage III colon cancer was… Expand
Is this relevant?
2012
2012
SummarySix weeks of treatment with carvedilol, N-696, celiprolol, dilevalol, acebutolol, urapidil, doxazosin and altiopril… Expand
  • figure 1
Is this relevant?
1991
1991
Vasorelaxant and hypotensive effects of tilisolol hydrochloride (N-696) in isolated rat thoracic aorta and pithed rats were… Expand
Is this relevant?
1985
1985
4-[3-(tert-Butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696) is a new beta-adrenoceptor blocking drug… Expand
Is this relevant?
1985
1985
Binding characteristics of the β-antagonists and agonists with the β-adrenoceptors were investigated in [3H] dihydroalprenolol… Expand
Is this relevant?
1984
1984
To characterize the pharmacological profile of a new beta-adrenoceptor blocker, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N… Expand
Is this relevant?
1984
1984
We evaluated antiarrhythmic effects of N-696 using canine digitalis ventricular arrhythmia models and electrophysiological… Expand
Is this relevant?
1984
1984
To assess the beta-blocking potencies of three newly synthesized beta-blockers, i.e., S-596: dl-2-(3'-t-butylamino-2… Expand
Is this relevant?
1982
1982
Seven drugs were tested for their antiarrhythmic effects on ventricular arrhythmias 24 and 48 hr after two-stage coronary… Expand
Is this relevant?